Strategic Plan Update

Under the leadership of President/CEO Dr. Larry Schlesinger and Executive Vice Presidents Dr. Joanne Turner and Bruce Edwards, Texas Biomed embarked on a journey in 2017 to establish a new strategic direction. The 10-year strategic plan was adopted in 2018, providing a road map to grow Texas Biomed’s people, places and programs.

2018

  • Texas Biomed set fighting infectious disease as its primary scientific mission
  • New Southwest National Primate Research Center (SNPRC) leadership recruited
  • New BSL3 and marmoset housing facility opened

2019

  • Office of Research worked collaboratively with scientists to establish scientific programs, named new program leads and co-leads
  • Vivarium established
  • Integrated SNPRC and Texas Biomed scientists and veterinary faculty

2020

  • Business Development unit established
  • Office of Research established new external Scientific Advisory Board
  • Recruitment kicked into high gear with new faculty and senior leadership
  • Texas Biomed played pivotal role in preclinical work on therapies and vaccines against COVID-19, while maintaining safe operations

2021

  • Education and Outreach Manager and Learning and Development Specialist hired to implement internal and external education programs
  • Launched first Global Health Symposium
  • Broke ground on Animal Care Complex

2022

  • Launch pre-design for Global Center for Bioscience
  • Work begins on Animal Care Complex
  • Since 2018, Texas Biomed has recruited 11 new faculty
  • To date, more than $50 million secured to implement the strategic plan, with capital campaign ongoing

2023-2027

  • Continue implementing education and training programs for internal team members and the community to build bridges of learning
  • Continue recruiting top talent to double size of scientific faculty from 20 to 40
  • Complete Animal Care Complex and break ground on Global Center for Bioscience
Other Articles
  • TEXAS BIOMED AND PARTNERS DISCOVER NEW, POTENT COVID-19 ANTIBODY COCKTAIL Texas Biomed researchers, led by Professor Luis Martinez-Sobrido, PhD, and collaborators at the University of Alabama at Birmingham, discovered a COVID-19 […]
  • SECRETS OF A CRITICAL SCHISTOSOMIASIS DRUG UNLOCKED For decades, no one really knew how the drug praziquantel treated schistosomiasis, a parasitic worm infection afflicting more than 200 million people worldwide. […]
  • FROM TRAINEE TO FACULTY Olena Shtanko, PhD, started at Texas Biomed in 2011 as a post-doctoral fellow, and has been an independent Staff Scientist for the past five years. When […]
  • Texas Biomed’s commitment to young people and science education has kicked into high gear in 2021 and 2022. Even while in-person campus tours were suspended due to the pandemic, the Education & Outreach team developed virtual campus tours for schools and afterschool clubs.